טוען...
Immunotherapy in Gynecologic Cancers: Are We There Yet?
Immune-targeted therapies have demonstrated durable responses in many tumor types with limited treatment options and poor overall prognosis. This has led to enthusiasm for expanding such therapies to other tumor types including gynecologic malignancies. The use of immunotherapy in gynecologic malign...
שמור ב:
| הוצא לאור ב: | Curr Treat Options Oncol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5936621/ https://ncbi.nlm.nih.gov/pubmed/28840453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-017-0504-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|